A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer

NCT03514836 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped insufficient accrual

Conditions

Castration-resistant Prostate Cancer

Interventions

BIOLOGICAL: DCVac/PCa
DRUG: Cyclophosphamide

Sponsor

SOTIO a.s.